High Prevalence of Molecular Markers Associated with Artemisinin, Sulfadoxine, and Pyrimethamine Resistance in Northern Namibia
The American Journal of Tropical Medicine and Hygiene · 03.11.2026 · 115 (5_Suppl) · 44-52
DOI: 10.4269/ajtmh.24-0870 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 03.11.2026. Verfasst von Lydia Eloff und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology, and Biotechnology, School of Science, University of Namibia, Windhoek, Namibia. Hauptthemen laut MEDLINE: Pyrimethamine, Sulfadoxine, Drug Resistance, Plasmodium falciparum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, NIAID NIH HHS.
Abstract (Originalsprache)
Artemisinin-based combination therapies are a cornerstone of Namibia’s efforts to eliminate malaria. Namibia has experienced a greater than 90% reduction in malaria cases since the introduction of these therapies in 2005. However, their efficacy has not been routinely monitored, with malaria outbreaks regularly reported since 2016. The recent emergence of artemisinin partial resistance in Africa has highlighted the role of malaria molecular surveillance in complementing efficacy studies. This cross-sectional genomic surveillance study was nested within Namibia’s routine surveillance system and aimed to determine the prevalence of antimalarial drug resistance markers in northern Namibia. Dried blood spots (DBS) and epidemiological data were collected from patients with confirmed Plasmodium falciparum cases who presented at health facilities in the highest malaria-burden regions (Zambezi, Kavango East, Kavango West, Ohangwena, and Omusati) from April to September 2023. Twelve genes associated with resistance to seven antimalarial drugs were genotyped from 264 DBS using multiplexed targeted amplicon sequencing. Multiple kelch 13 mutations associated with artemisinin partial resistance were identified: the P441L candidate marker was the most abundant, at 33.2%, and the P574L and A675V validated markers were observed in 1.2% of samples. The chloroquine resistance transporter C72/V73/M74I/N75E/K76T haplotype was observed in 1% of samples, whereas the multidrug resistance protein 1 N86 genotype, which is associated with reduced susceptibility to lumefantrine, was found in all samples. Although sulfadoxine–pyrimethamine is not used in Namibia, a high proportion of sulfadoxine–pyrimethamine resistance-associated mutations in the dihydropteroate synthase and dihydrofolate reductase genes were observed. In this study, we underscore the need for routine genomic surveillance to monitor emerging drug resistance markers and call for further research to define their clinical implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Microbiology, and Biotechnology, School of Science, University of Namibia, Windhoek, Namibia.
- Malaria Operational Research Program, Multidisciplinary Research Services, University of Namibia, Windhoek, Namibia.
- EPPIcenter Research Program, Department of Medicine, University of California, San Francisco, California, USA.
- Malaria Elimination Initiative, Institute of Global Health Sciences, University of California, San Francisco, California, USA.
- Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
- SADC Malaria Elimination Eight Secretariat, Windhoek, Namibia.
Förderung
- Bill & Melinda Gates Foundation
- NIAID NIH HHS
Zitieren
APA
Eloff, L., Aranda-Díaz, A., Routledge, I., Wesolowski, A., Chisenga, M., Mangena, B., Chimumbwa, J., Sikaala, C., Uusiku, P., Katokele, S., Raman, J., Smith, J. L., & Mumbengegwi, D. R. (2026). High Prevalence of Molecular Markers Associated with Artemisinin, Sulfadoxine, and Pyrimethamine Resistance in Northern Namibia. The American Journal of Tropical Medicine and Hygiene, 115(5_Suppl), 44-52. https://doi.org/10.4269/ajtmh.24-0870
Vancouver
Eloff L, Aranda-Díaz A, Routledge I, Wesolowski A, Chisenga M, Mangena B, et al. High Prevalence of Molecular Markers Associated with Artemisinin, Sulfadoxine, and Pyrimethamine Resistance in Northern Namibia. The American Journal of Tropical Medicine and Hygiene. 2026;115(5_Suppl):44-52. doi:10.4269/ajtmh.24-0870
BibTeX
@article{Eloff2026,
author = {Eloff, Lydia and Aranda-Díaz, Andrés and Routledge, Isobel and Wesolowski, Amy and Chisenga, Mukosha and Mangena, Brighton and Chimumbwa, John and Sikaala, Chadwick and Uusiku, Petrina and Katokele, Stark and Raman, Jaishree and Smith, Jennifer L and Mumbengegwi, Davis R},
title = {High Prevalence of Molecular Markers Associated with Artemisinin, Sulfadoxine, and Pyrimethamine Resistance in Northern Namibia},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
volume = {115},
number = {5_Suppl},
pages = {44--52},
doi = {10.4269/ajtmh.24-0870}
}
EUVIMED